Highest Price Target1
Lowest Price Target1
Consensus Price Target1
Analyst Rating Summary1
| Buy | Overweight | Hold | Underweight | Sell |
|---|---|---|---|---|
| 8 | 2 | 5 | 0 | 0 |
Analyst Firms Making Recommendations1
- UBS
- Morgan Stanley
- RBC Capital
- Needham
- Raymond James
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Hologic
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/16/2023 | HOLX | Buy Now | Hologic | $69.26 | 12.62% | UBS | Elizabeth Garcia | $91 → $78 | Maintains | Neutral | Get Alert |
| 11/13/2023 | HOLX | Buy Now | Hologic | $69.26 | 18.39% | Morgan Stanley | Tejas Savant | $86 → $82 | Maintains | Equal-Weight | Get Alert |
| 11/10/2023 | HOLX | Buy Now | Hologic | $69.26 | 3.96% | RBC Capital | Conor McNamara | $74 → $72 | Maintains | Sector Perform | Get Alert |
| 10/26/2023 | HOLX | Buy Now | Hologic | $69.26 | 19.84% | Needham | Mike Matson | $95 → $83 | Maintains | Buy | Get Alert |
| 10/18/2023 | HOLX | Buy Now | Hologic | $69.26 | 22.73% | Raymond James | Andrew Cooper | $95 → $85 | Maintains | Outperform | Get Alert |
| 10/05/2023 | HOLX | Buy Now | Hologic | $69.26 | 11.18% | RBC Capital | Conor McNamara | $81 → $77 | Maintains | Sector Perform | Get Alert |
| 08/01/2023 | HOLX | Buy Now | Hologic | $69.26 | 24.17% | Morgan Stanley | Tejas Savant | $86 → $86 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 08/01/2023 | HOLX | Buy Now | Hologic | $69.26 | 22.73% | Citigroup | Patrick Donnelly | $90 → $85 | Maintains | Neutral | Get Alert |
| 08/01/2023 | HOLX | Buy Now | Hologic | $69.26 | 22.73% | RBC Capital | Conor McNamara | $87 → $85 | Maintains | Sector Perform | Get Alert |
| 08/01/2023 | HOLX | Buy Now | Hologic | $69.26 | 24.17% | B of A Securities | Derik De Bruin | $94 → $86 | Maintains | Neutral | Get Alert |
| 08/01/2023 | HOLX | Buy Now | Hologic | $69.26 | 37.16% | Raymond James | Andrew Cooper | $100 → $95 | Maintains | Outperform | Get Alert |
| 08/01/2023 | HOLX | Buy Now | Hologic | $69.26 | 37.16% | Needham | Mike Matson | → $95 | Reiterates | Buy → Buy | Get Alert |
| 07/14/2023 | HOLX | Buy Now | Hologic | $69.26 | 37.16% | Needham | Mike Matson | → $95 | Upgrade | Hold → Buy | Get Alert |
| 06/15/2023 | HOLX | Buy Now | Hologic | $69.26 | 37.16% | Mizuho | Anthony Petrone | → $95 | Reiterates | Buy → Buy | Get Alert |
| 05/03/2023 | HOLX | Buy Now | Hologic | $69.26 | 24.17% | Morgan Stanley | Tejas Savant | $81 → $86 | Maintains | Equal-Weight | Get Alert |
| 05/02/2023 | HOLX | Buy Now | Hologic | $69.26 | 25.61% | RBC Capital | Conor McNamara | → $87 | Reiterates | → Sector Perform | Get Alert |
| 05/02/2023 | HOLX | Buy Now | Hologic | $69.26 | 51.6% | JP Morgan | Casey Woodring | $95 → $105 | Maintains | Overweight | Get Alert |
| 05/02/2023 | HOLX | Buy Now | Hologic | $69.26 | 22.73% | Wells Fargo | Timothy Daley | $80 → $85 | Maintains | Equal-Weight | Get Alert |
| 05/02/2023 | HOLX | Buy Now | Hologic | $69.26 | 44.38% | Raymond James | Andrew Cooper | $95 → $100 | Maintains | Outperform | Get Alert |
What is the target price for Hologic (HOLX)?
The latest price target for Hologic (NASDAQ: HOLX) was reported by UBS on November 16, 2023. The analyst firm set a price target for $78.00 expecting HOLX to rise to within 12 months (a possible 12.62% upside). 33 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Hologic (HOLX)?
The latest analyst rating for Hologic (NASDAQ: HOLX) was provided by UBS, and Hologic maintained their neutral rating.
When is the next analyst rating going to be posted or updated for Hologic (HOLX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Hologic, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Hologic was filed on November 16, 2023 so you should expect the next rating to be made available sometime around November 16, 2024.
Is the Analyst Rating Hologic (HOLX) correct?
While ratings are subjective and will change, the latest Hologic (HOLX) rating was a maintained with a price target of $91.00 to $78.00. The current price Hologic (HOLX) is trading at is $69.26, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.